نتائج البحث - "K.D. Penkov"

1

50 Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer: Longer follow-up results from the phase III EMPOWER-Lung 3 trial

المؤلفون: T. Makharadze, M. Gogishvili, T. Melkadze, A. Baramidze, D. Giorgadze, K.D. Penkov, K. Laktionov, G. Nemsadze, M. Nechaeva, I. Rozhkova, E. Kalinka, S. Li, Y. Li, M. Kaul, J-F. Pouliot, F. Seebach, I. Lowy, G. Gullo, P. Rietschel

المصدر: Journal of Thoracic Oncology. 18:S38-S39

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::9f44826cd617920ed4e9e0fb9ad43fac
https://doi.org/10.1016/s1556-0864(23)00259-9

View record in OpenAIRE

2

114M0 First-line cemiplimab for locally advanced non-small cell lung cancer: Updated subgroup analyses from EMPOWER-Lung 1 and EMPOWER-Lung 3

المؤلفون: E. Kalinka, I. Bondarenko, M. Gogishvili, T. Melkadze, A. Baramidze, A. Sezer, T. Makharadze, S. Kilickap, M. Gumus, K.D. Penkov, D. Giorgadze, M. Özgüroğlu, X. He, J-F. Pouliot, F. Seebach, I. Lowy, G. Gullo, P. Rietschel

المصدر: Journal of Thoracic Oncology. 18:S106

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::ba27546773360926d571e71f6bf4e29a
https://doi.org/10.1016/s1556-0864(23)00369-6

View record in OpenAIRE

3

318P EMPOWER-Lung 3: Cemiplimab in combination with platinum doublet chemotherapy for first-line (1L) treatment of advanced non-small cell lung cancer (NSCLC)

المؤلفون: M. Gogishvili, T. Melkadze, T. Makharadze, D. Giorgadze, M. Dvorkin, K.D. Penkov, K. Laktionov, G. Nemsadze, M. Nechaeva, I. Rozhkova, E. Kalinka, C. Gessner, B. Moreno Jaime, R. Passalacqua, S. Li, K. McGuire, R.G. Quek, G. Gullo, P. Rietschel

المصدر: Annals of Oncology. 33:S1567-S1568

مصطلحات موضوعية: Oncology, Hematology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::e8b219905abc8c88bc0268c10965cbc7
https://doi.org/10.1016/j.annonc.2022.10.361

View record in OpenAIRE

4

488P Phase I trial of PF-06821497, a potent and selective inhibitor of enhancer of zeste homolog 2 (EZH2), in follicular lymphoma (FL), small cell lung cancer (SCLC) and castration-resistant prostate cancer (CRPC)

المؤلفون: M. Schweizer, K.D. Penkov, A.W. Tolcher, A.D. Choudhury, V. Doronin, R. Aljumaily, E. Calvo, R.C. Frank, J.T. Hamm, V. Moreno Garcia, V. Vorobyev, S. Billotte, T. Bowler, J. Chen, T. Lin, L. Liu, A. Maity, S. Sharma, M.L. Johnson

المصدر: Annals of Oncology. 33:S763-S764

مصطلحات موضوعية: Oncology, Hematology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::48585f36d59850361eb8f132f862439f
https://doi.org/10.1016/j.annonc.2022.07.616

View record in OpenAIRE

5

954P Cemiplimab with platinum-based chemotherapy (chemo) for first-line (1L) locally advanced non-small cell lung cancer (laNSCLC): EMPOWER-Lung 3 subgroup analysis

المؤلفون: E. Kalinka-Warzocha, M. Gogishvili, T. Makharadze, M. Dvorkin, K.D. Penkov, K. Laktionov, M. Nechaeva, I. Rozhkova, X. He, R. Quek, J-F. Pouliot, F. Seebach, I. Lowy, G. Gullo, P. Rietschel

المصدر: Annals of Oncology. 33:S983-S984

مصطلحات موضوعية: Oncology, Hematology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::b015223e200fb57843efa0539a3889ca
https://doi.org/10.1016/j.annonc.2022.07.1080

View record in OpenAIRE

6

1261TiP CARMEN-GC01: Phase II, open-label, single-arm study of tusamitamab ravtansine in combination with ramucirumab in pretreated patients with gastric or gastroesophageal junction adenocarcinoma (GA/GEJA)

المؤلفون: F.M. Esposito, J. Lee, S.Y. Rha, K.D. Penkov, A. Moisseev, M. Van Den Eynde, H. Prenen, M. Díez García, M. Gumus, T. Sagawa, M. Nechaeva, T. Kajiwara, H. Harputluoglu, L. Charbonnier, S. Bensfia, N. Yang, D-Y. Oh

المساهمون: UCL - SSH/IACS - Institute of Analysis of Change in Contemporary and Historical Societies

المصدر: Annals of Oncology, Vol. 33, no.7, p. 1124 (2022)

مصطلحات موضوعية: Oncology, Hematology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::677730639d60a19a237e4d5cd58de896
https://hdl.handle.net/2078.1/273058

View record in OpenAIRE

7

181P SELECT: A phase II randomized trial evaluating 2 doses of vopratelimab (V) + pimivalimab (P) vs P in TISvopra selected patients (pts)

المؤلفون: M. Gumus, A. Sukalinskaya, Z.G. Andric, V. Cheshuk, T-E. Ciuleanu, S. Sezgin Goksu, T. Cil, I. Cicin, I.V. Bulat, Y.V. Ostapenko, K.D. Penkov, C. Hart, M. Lai, B. Chaao, J. Jimenez, A. Sepahi, G. Shi, S. Trott, E. Hooper

المصدر: Immuno-Oncology and Technology. 16:100293

مصطلحات موضوعية: Oncology, Immunology and Allergy

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::278d04ceafea0753ea41386e698c78a2
https://doi.org/10.1016/j.iotech.2022.100293

View record in OpenAIRE

8

122MO Cemiplimab (cemi) + platinum doublet chemotherapy (chemo) + ipilimumab (ipi) for first-line treatment of advanced non-small cell lung cancer (NSCLC): EMPOWER-Lung 3 part I

المؤلفون: A. Baramidze, M. Gogishvili, T. Melkadze, D. Giorgadze, K.D. Penkov, T. Makharadze, E. Kalinka, M. Nechaeva, K. Laktionov, C. Gessner, B. Moreno Jaime, R. Passalacqua, M.C. Garassino, S. Li, J-F. Pouliot, K. McGuire, R.G. Quek, M. Kaul, G. Gullo, P. Rietschel

المصدر: Immuno-Oncology and Technology. 16:100234

مصطلحات موضوعية: Oncology, Immunology and Allergy

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::cb7a4e90b85330a835f594c5e418a06a
https://doi.org/10.1016/j.iotech.2022.100234

View record in OpenAIRE

9

LBA68 Bempegaldesleukin (BEMPEG) plus nivolumab (NIVO) compared to the investigator’s choice of sunitinib or cabozantinib in previously untreated advanced renal cell carcinoma (RCC): Results from a phase III randomized study (PIVOT-09)

المؤلفون: N. Tannir, M.N. Formiga, N. Agarwal, S.K. Pal, D. Cho, D.J. George, W. Hong, L. Tang, A. Qureshi, M.A. Tagliaferri, J. Zalevsky, K.D. Penkov

المصدر: Annals of Oncology. 33:S1433

مصطلحات موضوعية: Oncology, Hematology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::0628772e45d1cfd4c604ccd2353efaab
https://doi.org/10.1016/j.annonc.2022.08.073

View record in OpenAIRE

10

1199P Dose modification for the management of CNS adverse events in the phase III CROWN study of lorlatinib in non-small cell lung cancer (NSCLC)

المؤلفون: K.D. Penkov, Anna Polli, Gerson Peltz, A.M. Calella, Benjamin Solomon, Holger Thurm, Todd M. Bauer, Y-L. Wu, Tony Mok, Hidetoshi Hayashi, O. Arrieta, Alessandra Bearz

المصدر: Annals of Oncology. 32:S957-S958

مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, medicine.medical_treatment, non-small cell lung cancer (NSCLC), Hematology, medicine.disease, Lorlatinib, Crown (dentistry), Internal medicine, Medicine, business, Adverse effect, Dose Modification

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::2bf453ca704e33613f2deee8bd32f9ae
https://doi.org/10.1016/j.annonc.2021.08.1804

View record in OpenAIRE

11

LBA51 EMPOWER-Lung 3: Cemiplimab in combination with platinum doublet chemotherapy for first-line (1L) treatment of advanced non-small cell lung cancer (NSCLC)

المؤلفون: Kristina McGuire, I. Rozhkova, E. Kalinka, Siyu Li, G. Nemsadze, P. Rietschel, T. Makharadze, B. Moreno-Jaime, M. Gogishvili, R. Passalacqua, C. Gessner, D. Giorgadze, Giuseppe Gullo, R.G.W. Quek, Mikhail Dvorkin, T. Melkadze, Marina Nechaeva, K. Laktionov, K.D. Penkov

المصدر: Annals of Oncology. 32:S1328

مصطلحات موضوعية: Chemotherapy, Lung, business.industry, medicine.medical_treatment, First line, non-small cell lung cancer (NSCLC), chemistry.chemical_element, Hematology, medicine.disease, medicine.anatomical_structure, Oncology, chemistry, medicine, Cancer research, Platinum, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::613a80071b9401ef85d03cecf4361fb6
https://doi.org/10.1016/j.annonc.2021.08.2130

View record in OpenAIRE

12

248. Breast recurrence after conservative surgery in patient with minimal (pT1a-bN0M0) breast cancer (significance of molecular subtype)

المؤلفون: K.U. Zernov, Bozhok Aa, P. Krivorotko, Vladimir Semiglazov, K.D. Penkov, A.M. Ermachenkova, I.A. Grechukhina, R.M. Paltuev, Vladislav Semiglazov

المصدر: European Journal of Surgical Oncology. 38:813

مصطلحات موضوعية: medicine.medical_specialty, Breast cancer, Oncology, business.industry, General surgery, medicine, Surgery, In patient, General Medicine, medicine.disease, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::ab2c6b4f97c5e1e6ba87917278df5a64
https://doi.org/10.1016/j.ejso.2012.06.242

View record in OpenAIRE

13

P181 Factors influencing prognosis in node-negative early breast cancer (p)T1N0M0

المؤلفون: Alexandr A. Bessonov, A.G. Vasiliev, A.A. Bozjok, G.A. Dashyan, K.D. Penkov, Vladimir Semiglazov, Alexey Manikhas, I.V. Nikitina, R.M. Paltuev, Vladislav Semiglazov

المصدر: The Breast. 20:S39

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Breast cancer, business.industry, Internal medicine, Medicine, Cancer, Surgery, General Medicine, business, medicine.disease, Early breast cancer, Node negative

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::284be2b69c4d56fdbcf9657da634c2f4
https://doi.org/10.1016/s0960-9776(11)70123-0

View record in OpenAIRE

تنقيح النتائج